Short Interest in Arteris, Inc. (NASDAQ:AIP) Increases By 15.6%

Arteris, Inc. (NASDAQ:AIP - Get Free Report) was the target of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 356,200 shares, an increase of 15.6% from the December 31st total of 308,100 shares. Currently, 1.4% of the shares of the stock are sold short. Based on an average daily volume of 204,000 shares, the days-to-cover ratio is presently 1.7 days.

Analysts Set New Price Targets

Separately, Rosenblatt Securities reaffirmed a "buy" rating and set a $15.00 target price on shares of Arteris in a research note on Wednesday, November 6th.

Insiders Place Their Bets

In related news, Director Isabelle F. Geday sold 15,550 shares of Arteris stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $9.03, for a total value of $140,416.50. Following the transaction, the director now directly owns 121,213 shares of the company's stock, valued at $1,094,553.39. The trade was a 11.37 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Nicholas B. Hawkins sold 19,299 shares of Arteris stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $8.14, for a total value of $157,093.86. Following the completion of the sale, the chief financial officer now owns 192,414 shares in the company, valued at approximately $1,566,249.96. This represents a 9.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 325,456 shares of company stock worth $3,355,352 in the last quarter. 33.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. US Bancorp DE bought a new stake in Arteris in the third quarter worth $34,000. R Squared Ltd bought a new position in Arteris in the 4th quarter worth about $64,000. Renaissance Technologies LLC grew its position in Arteris by 6.1% during the 2nd quarter. Renaissance Technologies LLC now owns 114,700 shares of the company's stock valued at $861,000 after purchasing an additional 6,600 shares during the last quarter. MetLife Investment Management LLC increased its stake in Arteris by 129.1% during the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company's stock valued at $131,000 after purchasing an additional 9,551 shares in the last quarter. Finally, The Manufacturers Life Insurance Company bought a new position in shares of Arteris in the second quarter worth approximately $86,000. Institutional investors own 64.36% of the company's stock.

Arteris Stock Down 2.3 %

Shares of NASDAQ AIP traded down $0.24 on Monday, reaching $10.38. 267,105 shares of the company's stock traded hands, compared to its average volume of 351,050. The business's 50 day simple moving average is $10.32 and its two-hundred day simple moving average is $8.57. Arteris has a 12 month low of $5.76 and a 12 month high of $12.64. The company has a market cap of $417.07 million, a price-to-earnings ratio of -10.78 and a beta of 1.18. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.